This study develops and tests a dynamic perspective on strategic fit. Drawing from contingency and resource-based arguments in the strategy and organizational theory literatures, we propose a ...

Celgene Corp's <CELG.O> $2.9 billion acquisition of Pharmion Corp <PHRM.O> would add products that fit snugly into its therapeutic focus on cancer and blood disorders, analysts said on Monday.